Join ICRF in Israel for ICRF Mission 2018: A Celebration of Israel and Israeli Science, and The Second Annual Jacki And Bruce Barron Cancer Research Scholars' Program Symposium

Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...

ICRF | Connecticut
Location: 
Oronoque Village, 600 North Trail, North Community Building
Date: 
Sunday, November 17, 2013

  &   

Present A Special Program & Brunch

Hear One of America's Premier Cancer Surgeons
and Researchers


Myron Arlen, M.D.
Principal and Founder, Neogenix Oncology


Eric G. Heffler
Executive Director
Israel Cancer Research Fund
 

TOPICThe Latest Advances in Cancer Research...
Could the Answer to Cancer Come from Israel?

Sunday, November 17, 11:00 a.m. ($10 for Brunch)
Oronoque Village, 600 North Trail, North Community Bldg
Stratford, CT  (Near Merritt Parkway, Exit 53)

Myron Arlen, MD has been involved in the surgery of advanced cancer problems and new therapeutic approaches. He established the Surgical Oncology Division at North Shore University Hospital, authored two major textbooks, and has published over 80 cancer-related journal articles.

Dr. Arlen, a Trustee of ICRF, is the principal founder of Neogenix Oncology whose mission is to improve and extend the lives of cancer patients by developing innovative diagnostics and therapeutics that target tumors with precision.

No Solicitation of Funds

ICRF is the largest U.S. charitable organization dedicated solely to the funding of cancer research in Israel. ICRF has provided $50 Million to fund 2,000 individual projects at 21 different Israel universities, hospitals and research institutes. 

The results are remarkable: the development of three FDA-approved anti-cancer drugs. Two of ICRF's most distinguished scientists were the first Israelis to be awarded the Nobel Prize in Science.

For information and reservations:
Lillian Schlager  203 380-8387
lillianschlager@yahoo.com

David Kweskin, Connecticut Area Director, ICRF 

City: 
Stratford, CT
Time: 
Sunday, November 17, 2013 - 11:00am